Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A QUICK Screen for Lrrk2 Interaction Partners – Leucine-rich Repeat Kinase 2 is Involved in Actin Cytoskeleton Dynamics
Andrea Meixner, Karsten Boldt, Marleen Van Troys, et al.
Molecular & Cellular Proteomics (2010) Vol. 10, Iss. 1, pp. M110.001172-M110.001172
Open Access | Times Cited: 124

Showing 26-50 of 124 citing articles:

LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
Jean‐Marc Taymans, Elisa Greggio
Current Neuropharmacology (2016) Vol. 14, Iss. 3, pp. 214-225
Open Access | Times Cited: 73
The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins
Mark S. Moehle, João Paulo Lima Daher, Travis D. Hull, et al.
Human Molecular Genetics (2015) Vol. 24, Iss. 15, pp. 4250-4267
Open Access | Times Cited: 72
Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain
Laura Civiero, Maria Daniela Cirnaru, Alexandra Beilina, et al.
Journal of Neurochemistry (2015) Vol. 135, Iss. 6, pp. 1242-1256
Open Access | Times Cited: 66
Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) for Quantitative Proteomics
Esthelle Hoedt, Guoan Zhang, Thomas A. Neubert
Advances in experimental medicine and biology (2019), pp. 531-539
Closed Access | Times Cited: 62
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
Paula Ramos-Gonzalez, Susana Mato, Juan Carlos Chara, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 49
RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors
Dan Dou, Jayne Aiken, Erika L.F. Holzbaur
The Journal of Cell Biology (2024) Vol. 223, Iss. 6
Open Access | Times Cited: 7
Micro-and mesoscale aspects of neurodegeneration in engineered human neural networks carrying the LRRK2 G2019S mutation
Vibeke Devold Valderhaug, Ola Huse Ramstad, Rosanne van de Wijdeven, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 7
Bcl2-associated Athanogene 3 Interactome Analysis Reveals a New Role in Modulating Proteasome Activity
Ying Chen, Li-Na Yang, Li Cheng, et al.
Molecular & Cellular Proteomics (2013) Vol. 12, Iss. 10, pp. 2804-2819
Open Access | Times Cited: 70
SNAP-25 regulates spine formation through postsynaptic binding to p140Cap
Romana Tomasoni, Daniele Repetto, Raffaella Morini, et al.
Nature Communications (2013) Vol. 4, Iss. 1
Open Access | Times Cited: 65
Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1
Gregory C. Luerman, Chuong Nguyen, Harry Samaroo, et al.
Journal of Neurochemistry (2013) Vol. 128, Iss. 4, pp. 561-576
Open Access | Times Cited: 63
Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease
Eugénie Mutez, Aurore Nkiliza, Karim Bélarbi, et al.
Neurobiology of Disease (2013) Vol. 63, pp. 165-170
Closed Access | Times Cited: 61
LRRK 2 localizes to endosomes and interacts with clathrin‐light chains to limit Rac1 activation
Andrea M. A. Schreij, Mathilde Chaineau, Wenjing Ruan, et al.
EMBO Reports (2014) Vol. 16, Iss. 1, pp. 79-86
Open Access | Times Cited: 58
Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration
Mareike Caesar, Susanne Zach, Coby B. Carlson, et al.
Neurobiology of Disease (2013) Vol. 54, pp. 280-288
Closed Access | Times Cited: 57
LRRK2 guides the actin cytoskeleton at growth cones together with ARHGEF7 and Tropomyosin 4
Karina Häbig, Sandra Gellhaar, Birgit Heim, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2013) Vol. 1832, Iss. 12, pp. 2352-2367
Open Access | Times Cited: 56
Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics
Farah H. Bardai, Dalila G. Ordonez, Rachel M. Bailey, et al.
PLoS Biology (2018) Vol. 16, Iss. 12, pp. e2006265-e2006265
Open Access | Times Cited: 53
LRRK2 Regulates Voltage-Gated Calcium Channel Function
Cade Henry Bedford, Catherine Sears, María Dolores Pérez‐Carrión, et al.
Frontiers in Molecular Neuroscience (2016) Vol. 9
Open Access | Times Cited: 50
LRRK2 modulates microglial activity through regulation of chemokine (C–X3–C) receptor 1 –mediated signalling pathways
Bo Ma, Leyan Xu, Xiaodong Pan, et al.
Human Molecular Genetics (2016) Vol. 25, Iss. 16, pp. 3515-3523
Open Access | Times Cited: 48
Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson’s disease
Gabriela Novak, Dimitrios Kyriakis, Kamil Grzyb, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 23
Studying post-translational modifications with protein interaction networks
Jonathan Woodsmith, Ulrich Stelzl
Current Opinion in Structural Biology (2013) Vol. 24, pp. 34-44
Open Access | Times Cited: 53
The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation
Susanna Cogo, Franz Y. Ho, Elena Tosoni, et al.
Brain Research (2022) Vol. 1778, pp. 147781-147781
Open Access | Times Cited: 21
Loss of LRRK2 activity induces cytoskeleton defects and oxidative stress during porcine oocyte maturation
Yuxia Wei, Ya-Han Wang, Xiaoting Yu, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention
Aaron J. Carman, John Koren III Wenjie Lou
Journal of Alzheimer’s Disease & Parkinsonism (2013) Vol. s10
Open Access | Times Cited: 43
On the Road to Leucine-Rich Repeat Kinase 2 Signalling: Evidence from Cellular and in vivo Studies
Veronique Daniëls, Veerle Baekelandt, Jean‐Marc Taymans
Neurosignals (2011) Vol. 19, Iss. 1, pp. 1-15
Open Access | Times Cited: 41
A visual review of the interactome of LRRK2: Using deep‐curated molecular interaction data to represent biology
Pablo Porras, Margaret Duesbury, Antonio Fabregat, et al.
PROTEOMICS (2015) Vol. 15, Iss. 8, pp. 1390-1404
Open Access | Times Cited: 39
ERKed by LRRK2: A cell biological perspective on hereditary and sporadic Parkinson's disease
Manish Verma, Erin Steer, Charleen T. Chu
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2013) Vol. 1842, Iss. 8, pp. 1273-1281
Open Access | Times Cited: 37

Scroll to top